Medicaid Pharmaceutical & Therapeutics
Committee
The purpose of the Medicaid Pharmaceutical
& Therapeutics Committee is to develop and implement a voluntary Medicaid preferred
prescribed drug designation program, as mandated in the 2000 session of the
Florida legislature,
SB 2034.
Committee Members
Florida Statute 409.91195 requires the appointment of committee
members by the Governor.
Schedule of Meetings
Please follow this link to
see information regarding the next scheduled meetings for the
Pharmaceutical and Therapeutics Committee, the Drug Utilization Review
Board, and the Prescribing Pattern Review Panel.
Florida Medicaid
Preferred Drug List. The Florida Medicaid Preferred Drug List (PDL)
is a listing of prescription products selected by the Pharmaceutical & Therapeutics
Committee as cost effective choices for clinician consideration when prescribing
for Medicaid recipients. The PDL will be used to inform clinicians of effective
products that provide favorable net costs to Medicaid. The PDL educates clinicians
about cost effective choices in prescribing for Medicaid recipients, but clinicians
always retain the option of selecting the drug product they feel is most appropriate
for their patient by calling the Therapeutic Consultation Program at (877) 553-7481.
If the prescriber cannot readily obtain authorization the pharmacist may dispense
a 72 hour supply. The pharmacist may also use their professional judgement if
other situations arise that would necessitate a 72 hour emergency supply.
|
